Mybboo/Mybboo
involves: C57BL/6
|
abnormal B cell differentiation |
J:167270
|
abnormal common lymphocyte progenitor cell morphology |
J:167270
|
abnormal definitive hematopoiesis |
J:167270
|
abnormal embryonic erythropoiesis |
J:167270
|
abnormal erythrocyte morphology |
J:167270
|
abnormal erythropoiesis |
J:167270
|
abnormal leukocyte morphology |
J:167270
|
abnormal megakaryocyte morphology |
J:167270
|
abnormal spleen morphology |
J:167270
|
anemia |
J:167270
|
decreased neutrophil cell number |
J:167270
|
decreased spleen white pulp amount |
J:167270
|
enlarged spleen |
J:167270
|
increased hematopoietic stem cell number |
J:167270
|
increased megakaryocyte cell number |
J:167270
|
increased nucleated erythrocyte cell number |
J:167270
|
increased number of Howell-Jolly bodies |
J:167270
|
increased spleen red pulp amount |
J:167270
|
polychromatophilia |
J:167270
|
reticulocytosis |
J:167270
|
thrombocytosis |
J:167270
|
MybM303V/MybM303V
involves: 129S1/SvlmJ * C57BL/6
|
abnormal megakaryocyte differentiation |
J:96507
|
abnormal platelet shape |
J:96507
|
absent common myeloid progenitor cells |
J:96507
|
anemia |
J:96507
|
arrested B cell differentiation |
J:96507
|
arrested T cell differentiation |
J:96507
|
decreased B cell number |
J:96507
|
decreased eosinophil cell number |
J:96507
|
decreased erythrocyte cell number |
J:96507
|
decreased single-positive T cell number |
J:96507
|
decreased thymocyte number |
J:96507
|
increased bone marrow cell number |
J:96507
|
increased hematopoietic stem cell number |
J:96507
|
macrocytosis |
J:96507
|
thrombocytosis |
J:96507
|
Mybtm1.1Cgn/Myb+
involves: 129P2/OlaHsd * C57BL/6
|
arrested B cell differentiation |
J:127234
|
decreased B-1 B cell number |
J:127234
|
decreased mature B cell number |
J:127234
|
decreased pre-B cell number |
J:127234
|
Mybtm1.1Cgn/Mybtm1.1Cgn
involves: 129P2/OlaHsd * C57BL/6
|
anemia |
J:91122
|
lethality throughout fetal growth and development, complete penetrance |
J:91122
|
Mybtm1.1Jof/Mybtm1.1Jof
involves: 129/Sv * C57BL/6
|
no abnormal phenotype detected |
J:85344
|
Mybtm1b(KOMP)Wtsi/Myb+
C57BL/6N-Mybtm1b(KOMP)Wtsi/Ucd
|
abnormal heart morphology |
J:211773
|
anophthalmia |
J:211773
|
enlarged heart |
J:211773
|
hemorrhage |
J:211773
|
microcephaly |
J:211773
|
microphthalmia |
J:211773
|
polydactyly |
J:211773
|
spina bifida |
J:211773
|
syndactyly |
J:211773
|
Mybtm1b(KOMP)Wtsi/Mybtm1b(KOMP)Wtsi
C57BL/6N-Mybtm1b(KOMP)Wtsi/Ucd
|
anophthalmia |
J:211773
|
hemorrhage |
J:211773
|
microcephaly |
J:211773
|
microphthalmia |
J:211773
|
pallor |
J:211773
|
polydactyly |
J:211773
|
preweaning lethality, incomplete penetrance |
J:211773
|
spina bifida |
J:211773
|
syndactyly |
J:211773
|
Mybtm1Cgn/Mybtm1.1Cgn
involves: 129P2/OlaHsd * C57BL/6
|
no abnormal phenotype detected |
J:91122
|
Mybtm1Cgn/Mybtm1.1Cgn Tg(Lck-cre)548Jxm/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
|
decreased CD4-positive, alpha-beta T cell number |
J:91122
|
decreased double-positive T cell number |
J:91122
|
thymus hypoplasia |
J:91122
|
Mybtm1Cgn/Mybtm1Cgn Tg(Lck-cre)1Cwi/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
|
arrested T cell differentiation |
J:91122
|
decreased CD4-positive, alpha-beta T cell number |
J:91122
|
decreased CD8-positive, alpha-beta T cell number |
J:91122
|
decreased double-negative T cell number |
J:91122
|
decreased double-positive T cell number |
J:91122
|
decreased gamma-delta T cell number |
J:91122
|
thymus hypoplasia |
J:91122
|
Mybtm1Cgn/Mybtm1Cgn Tg(Lck-cre)548Jxm/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
|
decreased CD4-positive, alpha-beta T cell number |
J:91122
|
decreased double-positive T cell number |
J:91122
|
thymus hypoplasia |
J:91122
|
Mybtm1Epr/Mybtm1Epr Tg(Cd4-cre)1Cwi/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2
|
abnormal T cell differentiation |
J:93481
|
decreased CD4-positive, alpha-beta T cell number |
J:93481
|
decreased double-positive T cell number |
J:93481
|
increased CD8-positive, alpha-beta T cell number |
J:93481
|
thymus hypoplasia |
J:93481
|
Mybtm1Epr/Mybtm1Epr Tg(Lck-cre)548Jxm/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA
|
abnormal double-negative T cell morphology |
J:93481
|
abnormal T cell differentiation |
J:93481
|
decreased double-positive T cell number |
J:93481
|
thymus hypoplasia |
J:93481
|
Mybtm1Jof/Mybtm1Jof
involves: 129/Sv * C57BL/6
|
abnormal B cell differentiation |
J:85344
|
abnormal definitive hematopoiesis |
J:85344
|
abnormal double-negative T cell morphology |
J:85344
|
abnormal erythropoiesis |
J:85344
|
abnormal liver development |
J:85344
|
abnormal myeloblast morphology/development |
J:85344
|
abnormal T cell differentiation |
J:85344
|
decreased body size |
J:85344
|
decreased thymocyte number |
J:85344
|
increased megakaryocyte cell number |
J:85344
|
premature death |
J:85344
|
Mybtm1Jof/Mybtm1Ssp
involves: 129/Sv * C57BL/6
|
abnormal definitive hematopoiesis |
J:85344
|
abnormal erythropoiesis |
J:85344
|
abnormal liver development |
J:85344
|
abnormal myeloblast morphology/development |
J:85344
|
abnormal T cell differentiation |
J:85344
|
decreased thymocyte number |
J:85344
|
increased megakaryocyte cell number |
J:85344
|
lethality throughout fetal growth and development, complete penetrance |
J:85344
|
Mybtm1Ssp/Mybtm1Ssp
either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1)
|
abnormal erythropoiesis |
J:43747
|
abnormal liver sinusoid morphology |
J:43747
|
anemia |
J:43747
|
decreased common myeloid progenitor cell number |
J:43747
|
decreased erythroid progenitor cell number |
J:43747
|
decreased hematocrit |
J:43747
|
decreased hematopoietic stem cell number |
J:43747
|
increased nucleated erythrocyte cell number |
J:43747
|
lethality throughout fetal growth and development, complete penetrance |
J:43747
|
pallor |
J:43747
|
small liver |
J:43747
|
Mybtm1Ssp/Mybtm1Ssp
involves: 129S2/SvPas
|
abnormal angiogenesis |
J:63424
|
abnormal definitive hematopoiesis |
J:63424
|
abnormal erythropoiesis |
J:63424
|
abnormal hematopoietic stem cell morphology |
J:63424
|
Mybtm2.2Epr/Mybtm2.2Epr
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
|
normal
hematopoietic system phenotype |
J:160189
|
normal
immune system phenotype |
J:160189
|
normal
mortality/aging |
J:160189
|
Tg(CD2-Myb/en)2Kmw/?
involves: C57BL/10 * CBA
|
abnormal single-positive T cell number |
J:126456
|
decreased T cell number |
J:126456
|
decreased T cell proliferation |
J:126456
|
increased double-negative T cell number |
J:126456
|
Tg(CD2-Myb/en)2Kmw/Tg(CD2-Myb/en)2Kmw
involves: C57BL/10 * CBA
|
decreased body size |
J:126456
|
decreased double-positive T cell number |
J:126456
|
decreased T cell number |
J:126456
|
decreased T cell proliferation |
J:126456
|
increased double-negative T cell number |
J:126456
|
premature death |
J:126456
|
small spleen |
J:126456
|
small thymus |
J:126456
|